Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection
Tóm tắt
Từ khóa
Tài liệu tham khảo
Carfì A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603.
Living with Covid19 [Internet]. National Institute for Health Research; 2020 Oct [cited 2020 Nov 13]. Available from: https://evidence.nihr.ac.uk/themedreview/living-with-covid19/
Covid Long Haulers Describe the Devastating Aftereffects of the Disease. Bloomberg.com [Internet]. 2020 Nov 9 [cited 2020 Dec 5]; Available from: https://www.bloomberg.com/news/features/2020-11-09/coronavirus-long-haulers-tell-us-their-symptoms-and-the-aftereffects-of-disease
Long Covid: ‘Is this now me forever?’ [Internet]. the Guardian. 2020 [cited 2020 Dec 5]. Available from: http://www.theguardian.com/world/2020/nov/29/eleanor-morgan-is-still-struggling-with-long-covid-months-after-catching-the-virus
Martinez MW, Tucker AM, Bloom OJ, Green G, DiFiori JP, Solomon G, et al. Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening. JAMA Cardiol [Internet]. 2021 Mar 4 [cited 2021 Jun 1]; Available from: https://jamanetwork.com/journals/jamacardiology/fullarticle/2777308
Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med [Internet]. 2021 May 5 [cited 2021 Jun 1];0(0). Available from: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00174-0/abstract
Pero A, Ng S, Cai D. COVID-19: a perspective from clinical neurology and neuroscience. Neuroscientist. 2020;26(5–6):387–91.
Chopra V, Flanders SA, O’Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2020;174(4):576–8.
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. 2021;397(10270):220–32.
Ramos-Casals M, Brito-Zerón P, Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol. 2021;17(6):315–32.
Prevalence of long COVID symptoms and COVID-19 complications - Office for National Statistics [Internet]. [cited 2020 Dec 16]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/datasets/prevalenceoflongcovidsymptomsandcovid19complications
Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, et al. Long-term consequences of COVID-19: research needs. Lancet Infect Dis. 2020;20(10):1115–7.
Raveendran AV. Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndr Clin Res Rev. 2021;15(1):145–6.
Salje H, Kiem CT, Lefrancq N, Courtejoie N, Bosetti P, Paireau J, et al. Estimating the burden of SARS-CoV-2 in France. Science. 2020;369(6500):208–11.
Cruccu G, Sommer C, Anand P, Attal N, Baron R, Garcia-Larrea L, et al. EFNS guidelines on neuropathic pain assessment: revised 2009: Neuropathic pain assessment. Eur J Neurol. 2010;17(8):1010–8.
Perrot S, Bouhassira D, Fermanian J. Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST): Pain. 2010;150(2):250–6.
Rodero MP, Decalf J, Bondet V, Hunt D, Rice GI, Werneke S, et al. Detection of interferon alpha protein reveals differential levels and cellular sources in disease. J Exp Med. 2017;214(5):1547–55.
Roberge P. A psychometric evaluation of the French Canadian version of the Hospital Anxiety and Depression Scale in a large primary care population. J Affect Disord. 2013;9.
Bovin MJ, Marx BP, Weathers FW, Gallagher MW, Rodriguez P, Schnurr PP, et al. Psychometric properties of the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (PCL-5) in veterans. Psychol Assess. 2016;28(11):1379–91.
Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;m3026.
Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, et al. Persistent symptoms after Covid-19: qualitative study of 114 “long Covid” patients and draft quality principles for services. BMC Health Serv Res. 2020;20(1):1144.
Schwarzkopf S, Krawczyk A, Knop D, Klump H, Heinold A, Heinemann FM, et al. Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG - Volume 27, Number 1—January 2021 - Emerging Infectious Diseases journal - CDC. [cited 2021 Jun 1]; Available from: https://wwwnc.cdc.gov/eid/article/27/1/20-3772_article
Ibarrondo FJ, Fulcher JA, Goodman-Meza D, Elliott J, Hofmann C, Hausner MA, et al. Rapid decay of anti–SARS-CoV-2 antibodies in persons with mild Covid-19. N Engl J Med. 2020;383(11):1085–7.
Tonn T, Corman VM, Johnsen M, Richter A, Rodionov RN, Drosten C, et al. Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma. Lancet Microbe. 2020;1(2):e63.
Gallais F, Velay A, Nazon C, Wendling M-J, Partisani M, Sibilia J, et al. Intrafamilial exposure to SARS-CoV-2 associated with cellular immune response without seroconversion, France. Emerg Infect Dis. 2021;27(1):113–21.
Amanzio M, Howick J, Bartoli M, Cipriani GE, Kong J. How do nocebo phenomena provide a theoretical framework for the COVID-19 pandemic? Front Psychol. 2020;11:589884.
Kwong ASF, Pearson RM, Adams MJ, Northstone K, Tilling K, Smith D, et al. Mental health before and during COVID-19 in two longitudinal UK population cohorts. Br J Psychiatry. 2020;24:1–27.
Liu CH, Zhang E, Wong GTF, Hyun S, Hahm H “Chris”. Factors associated with depression, anxiety, and PTSD symptomatology during the COVID-19 pandemic: Clinical implications for U.S. young adult mental health. Psychiatry Res. 2020;290:113172.
Ghosn J, Piroth L, Epaulard O, Turnier PL, Mentré F, Bachelet D, et al. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect [Internet]. 2021 May 10 [cited 2021 May 20];0(0). Available from: https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(21)00147-6/abstract
Covid-19 will be followed by a deconditioning pandemic [Internet]. The BMJ. 2020 [cited 2021 Jan 3]. Available from: https://blogs.bmj.com/bmj/2020/06/15/covid-19-will-be-followed-by-a-deconditioning-pandemic/
Butler M, Pollak TA, Rooney AG, Michael BD, Nicholson TR. Neuropsychiatric complications of covid-19. BMJ. 2020 Oct 13;371:m3871.
Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies. Clin Med Lond Engl. 2021;21(1):e63–7.
Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;19:1–9.
Jøntvedt Jørgensen M, Holter JC, Christensen EE, Schjalm C, Tonby K, Pischke SE, et al. Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19. Sci Rep. 2020;10(1):21697.